UBS Group’s CNOVA N.V. CNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-63
Closed 8355
2016
Q4
$0 Sell
63
-2,013
-97% -$10.9K ﹤0.01% 8335
2016
Q3
$11K Sell
2,076
-706
-25% -$3.64K ﹤0.01% 6757
2016
Q2
$14K Sell
2,782
-1,108
-28% -$4.7K ﹤0.01% 6596
2016
Q1
$12K Buy
3,890
+1,980
+104% +$4.75K ﹤0.01% 6576
2015
Q4
$5K Sell
1,910
-499
-21% -$1.44K ﹤0.01% 7731
2015
Q3
$7K Sell
2,409
-112,399
-98% -$524K ﹤0.01% 7547
2015
Q2
$635K Buy
114,808
+112,197
+4,297% +$670K ﹤0.01% 3915
2015
Q1
$16K Buy
2,611
+439
+20% +$2.89K ﹤0.01% 7247
2014
Q4
$17K Buy
+2,172
New +$15.7K ﹤0.01% 7917

Other funds holding CNV

UBS Group's CNV Position: Q1 2017 in Review

UBS Group sold out of CNOVA N.V. (CNV) in Q1 2017, closing a stake of 63 shares.

UBS Group first reported a position in CNV in Q4 2014 and held it in 9 quarters. The position peaked at $635K in Q2 2015. 2 funds tracked by Wall St. Rank hold CNV as of Q1 2017.

  • UBS Group reported no remaining CNOVA N.V. position as of Q1 2017 after selling out during the quarter.
  • UBS Group sold 63 CNOVA N.V. shares in Q1 2017.
  • UBS Group first reported a position in CNOVA N.V. in Q4 2014 and held it in 9 quarters.
  • UBS Group's CNOVA N.V. position peaked at $635K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held CNOVA N.V. as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.